Rheumatologic Toxicities
Rheumatologic Toxicities is a clinical construct referring to immune-mediated adverse events characterized by inflammatory musculoskeletal manifestations, such as arthritis, myositis, or sicca syndrome, that arise secondary to immune checkpoint inhibitor therapy.
127
Publications
5.7K
Citations
538
Authors
160
Institutions
Publications per year
2017–2026
15
Variants
Rheumatologic Immune-related Adverse EventsRheumatologic Iraes
127
Efficacy of tramadol in treatment of chronic low back pain.
Thomas J. Schnitzer, W. Gray, Robert Zorba Paster et al. · PubMed · 2000 · 208 citations
Life Sciences, Immunology, Pathology +11
Christine A. Iacobuzio–Donahue, Edward L. Lee, Susan C. Abraham et al. · The American Journal of Surgical Pathology · 2001 · 156 citations
Medicine, Pharmacology, Toxicology +13
1–5 of 127
538
4
h-index
3
h-index
3
h-index
2
h-index
2
h-index
1–5 of 538
160
Stanford University
Stanford, United States
4 h-index
7 publications
606 citations

University of Alabama at Birmingham
Birmingham, United States
4 h-index
13 publications
949 citations

Johns Hopkins University
Baltimore, United States
3 h-index
9 publications
239 citations
Massachusetts General Hospital
Boston, United States
3 h-index
15 publications
1.2K citations

Radboud University Nijmegen
Nijmegen, The Netherlands
3 h-index
8 publications
482 citations
Harvard University
Cambridge, United States
3 h-index
25 publications
1.6K citations
Center for Rheumatology
Albany, United States
3 h-index
7 publications
177 citations
University of Florida
Gainesville, United States
2 h-index
4 publications
204 citations
1–8 of 160
Repository · 37 publications · 1.7K citations
24
h-index
ARD · 9 publications · 455 citations
9
h-index
9 publications · 303 citations
9
h-index
8 publications · 564 citations
8
h-index
5 publications · 194 citations
5
h-index
1–5